* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

NicOx

NicOx announces that Pfizer has disclosed further details of glaucoma trial for PF-03187207...

yahoo.com
Feb 26, 2008 11 related
        

SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Mar 29, 2007 -- NicOx S.A. (Eurolist : COX) today announced that additional information has been communicated by Pfizer Inc (NYSE:PFE - The disclosures which have been made by Pfizer specify that this trial is a phase 2,...

add comment

NicOx reports TOPIGEN to advance TPI-1020 into phase 2 for COPD following promising clinical...

yahoo.com
Feb 26, 2008 2 related
        

Tuesday September 11, 1:12 am ET SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Sep 11, 2007 -- Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today reported that TOPIGEN Pharmaceuticals Inc. has disclosed promising top-line results from its first phase 2...

add comment

NicOx initiates second phase 3 study to confirm naproxcinod's efficacy and improved blood...

yahoo.com
Feb 22, 2008 5 related
        

Tuesday April 3, 2007 1:06 am ET SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Apr 3, 2007 -- NicOx S.A. (Eurolist: COX) today announced that it has initiated the second pivotal phase 3 trial for naproxcinod in patients with osteoarthritis of the knee (the 302 study). Michele...

add comment

NicOx reports first quarter 2007 financial results (Marketwire)

yahoo.com
Feb 22, 2008 4 related
        

SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--May 11, 2007 -- www.nicox.com NicOx S.A. (Eurolist: COX) today reported financial results for the quarter ended March 31, 2007 and provided an update on its collaboration with Axcan Pharma Inc. in chronic liver diseases (see...

add comment

NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States (Marketwire)

yahoo.com
Feb 22, 2008 2 related
        

Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today announced that it has recruited Sanjiv Sharma as Vice President of Commercial Affairs. Mr. Sharma will be responsible for implementing a global commercial strategy for NicOx' portfolio and defining...

add comment

NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization...

yahoo.com
Feb 22, 2008
        

SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Jul 2, 2007 -- In this role Dr. Pfister will report to Michele Garufi, Chairman and CEO, and will have overall responsibility for NicOx' Research and Development (R&D) activities, notably the Research, Regulatory Affairs, Clinical...

add comment

NicOx reports results for the first nine months of 2007 (Marketwire)

yahoo.com
Feb 21, 2008 15 related
        

October 29, 2007. Sophia Antipolis, France. www.nicox.com ... Monday October 29, 2:08 am ET SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Oct 29, 2007 -- Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today reported financial results for the nine months...

add comment

NicOx announces TOPIGEN initiates phase 2 proof of concept study in COPD for TPI 1020 (Marketwire)

yahoo.com
Feb 21, 2008
        

www.nicox.com ... NicOx S.A. (Eurolist: COX) today announced that TOPIGEN Pharmaceuticals Inc. has dosed the first patients in a phase 2 proof of concept study for TPI 1020 in Chronic Obstructive Pulmonary Disease (COPD) - see TOPIGEN press release attached. This new...

add comment

NicOx and Ferrer present promising clinical and preclinical results in dermatology (Marketwire)

yahoo.com
Feb 21, 2008
        

Tuesday October 2, 1:11 am ET SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Oct 2, 2007 -- October 2, 2007. www.nicox.com NicOx S.A. (Eurolist: COX) today announced the presentation of promising clinical and preclinical results from its collaboration with Ferrer Grupo...

add comment